Jeffery Harris
Board Member @ Somna Therapeutics
Milwaukee, United States
Jeffery Harris is a seed investor at Somna Therapeutics in Milwaukee focused on Medical and Health Care. Jeff Harris is an investor in and board member of Somna Therapeutics and Okanjo Partners, Inc., early stage technology companies located in Wisconsin. He is an investor and board member of Guy & O’Neill, a Wisconsin manufacturing company, and a director of AMN Healthcare Services, Inc., a healthcare staffing company based in San Diego (NYSE:AHS). He has served as a director of Sybron Dental Specialties, Inc. prior to its sale to Danaher Corporation, Playtex Products, Inc. prior to its sale to Energizer Holdings, Inc., and Apogent Technologies Inc. prior to its merger with Fisher Scientific. Prior to becoming a director of Apogent, Mr. Harris served as Vice President-General Counsel and Secretary of Apogent (formerly known as Sybron International Corporation), a diversified manufacturer of laboratory and life science products for worldwide clinical, research and industrial markets. Prior to joining Sybron, Mr. Harris was an associate with the law firm of Baker & Hostetler. He practiced law in that firm’s Cleveland and Denver offices. Mr. Harris earned a B.S. in Economics from Ohio Wesleyan University, and a J.D. from The Ohio State University College of Law. He is a member of the Colorado, Ohio and Wisconsin Bar Associations. Mr. Harris is on the Board of Brookfield Academy, and is a founder and the Chairman of the Board of BrightStar Wisconsin Foundation, Inc.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Jeffery Harris invests in
Stages Jeffery Harris invests in
Countries Jeffery Harris invests in
Investment Focus
Industry
- Medical 1 (100%)
- Health Care 1 (100%)
- Clinical Trials 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Somna Therapeutics
|
Founded in March 2012 in partnership with the Medical College of Wisconsin, Somna Therapeutics is a medical device company focused on improving the quality of life for the millions of people suffering from laryngopharyngeal reflux (LPR) / extraesophageal acid reflux disease (EERD). The Reza Band™, UES Assist Device is designed to be anon-invasive solution. In the near-term, Somna Therapeutics is planning to optimize product design and complete clinical trials to gain FDA clearance. We anticipate upon FDA clearance and product launch, to be selling to hospitals, physician clinics, and home health care. | $1.2M / Seed / May 02, 2012 |
About Somna Therapeutics
Founded in March 2012 in partnership with the Medical College of Wisconsin, Somna Therapeutics is a medical device company focused on improving the quality of life for the millions of people suffering from laryngopharyngeal reflux (LPR) / extraesophageal acid reflux disease (EERD). The Reza Band™, UES Assist Device is designed to be anon-invasive solution. In the near-term, Somna Therapeutics is planning to optimize product design and complete clinical trials to gain FDA clearance. We anticipate upon FDA clearance and product launch, to be selling to hospitals, physician clinics, and home health care.
Somna Therapeutics Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Jeffery Harris
Board Member
|
|||
Laura Hudziak Jackson
VP of Sales and Marketing
|
|||
Reza Shaker
Founder
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Jeffery Harris invest in?
Jeffery Harris invests primarily in Medical, Health Care and Clinical Trials startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Jeffery Harris last invest?
The most recent investment recorded for Jeffery Harris closed in May 2012. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
